Andra Ap Fonden I Mab Transaction History

Andra Ap Fonden

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$8.27 - $18.43 $727,760 - $1.62 Million	-88,000 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$45.28 - $74.5 $2.01 Million - $3.32 Million	44,500 Added 102.3%	88,000 $4.17 Million
Q3 2021 Nov 12, 2021	BUY	$57.18 - $84.43 $468,876 - $692,326	8,200 Added 23.23%	43,500 $3.15 Million
Q2 2021 Aug 16, 2021	BUY	$47.86 - $83.95 $1.69 Million - $2.96 Million	35,300 New	35,300 $2.96 Million

16M

11.9K

3.5K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $130M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

Stay updated on Andra Ap Fonden with notifications on news.